Mary Jane Plym

1.4k total citations
9 papers, 987 citations indexed

About

Mary Jane Plym is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Mary Jane Plym has authored 9 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Hepatology. Recurrent topics in Mary Jane Plym's work include Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers) and Pain Mechanisms and Treatments (2 papers). Mary Jane Plym is often cited by papers focused on Hepatitis B Virus Studies (3 papers), Hepatitis C virus research (3 papers) and Pain Mechanisms and Treatments (2 papers). Mary Jane Plym collaborates with scholars based in United States, Australia and Germany. Mary Jane Plym's co-authors include Ann W. Walsh, Kevin A. Pokornowski, Steven M. LeVine, Daniel J. Tenney, Richard J. Colonno, Sharon Zhang, Mayla Hsu, Betsy J. Eggers, Jie Fang and Carl J. Baldick and has published in prestigious journals such as Hepatology, Cancer Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Mary Jane Plym

9 papers receiving 958 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Jane Plym United States 8 851 830 171 75 34 9 987
Stephanie Fang–Tzu Kuo Australia 15 1.1k 1.3× 1.1k 1.3× 31 0.2× 105 1.4× 31 0.9× 19 1.2k
Lucy Costantino Italy 14 394 0.5× 353 0.4× 30 0.2× 101 1.3× 142 4.2× 27 704
Wiesław Kryczka Poland 12 483 0.6× 479 0.6× 51 0.3× 106 1.4× 36 1.1× 34 651
Emilio Suárez Spain 8 723 0.8× 705 0.8× 58 0.3× 52 0.7× 30 0.9× 14 843
Hye Young Chang South Korea 15 456 0.5× 425 0.5× 39 0.2× 54 0.7× 37 1.1× 36 567
Takeaki Satoh Japan 13 515 0.6× 560 0.7× 78 0.5× 50 0.7× 7 0.2× 35 624
Kornelija Suveizdytė United Kingdom 6 234 0.3× 156 0.2× 106 0.6× 57 0.8× 27 0.8× 6 474
Jean‐Baptiste Trabut France 10 339 0.4× 294 0.4× 33 0.2× 78 1.0× 19 0.6× 25 460
Herbert L. Lim United States 8 237 0.3× 276 0.3× 15 0.1× 38 0.5× 17 0.5× 9 381
Chiharu Ohue Japan 8 280 0.3× 323 0.4× 37 0.2× 84 1.1× 20 0.6× 10 421

Countries citing papers authored by Mary Jane Plym

Since Specialization
Citations

This map shows the geographic impact of Mary Jane Plym's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Jane Plym with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Jane Plym more than expected).

Fields of papers citing papers by Mary Jane Plym

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Jane Plym. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Jane Plym. The network helps show where Mary Jane Plym may publish in the future.

Co-authorship network of co-authors of Mary Jane Plym

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Jane Plym. A scholar is included among the top collaborators of Mary Jane Plym based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Jane Plym. Mary Jane Plym is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Duignan, Inga, Erik Corcoran, Mary Jane Plym, et al.. (2011). Pleiotropic Stromal Effects of Vascular Endothelial Growth Factor Receptor 2 Antibody Therapy in Renal Cell Carcinoma Models. Neoplasia. 13(1). 49–59. 14 indexed citations
2.
Surguladze, David, Mary Jane Plym, Marie Prewett, et al.. (2010). 231 Efficacy of VEGFR2 targeted mAb therapy in preclinical cancer models resistant to antiangiogenic therapy. European Journal of Cancer Supplements. 8(7). 75–75. 1 indexed citations
3.
Surguladze, David, Dhanvanthri S. Deevi, Erik Corcoran, et al.. (2009). Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice. Cancer Research. 69(14). 5643–5647. 40 indexed citations
4.
Colonno, Richard J., Ronald E. Rose, Carl J. Baldick, et al.. (2006). Entecavir resistance is rare in nucleoside naïve patients with hepatitis B. Hepatology. 44(6). 1656–1665. 276 indexed citations
5.
Tenney, Daniel J., Ronald E. Rose, Carl J. Baldick, et al.. (2006). Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions Present. Antimicrobial Agents and Chemotherapy. 51(3). 902–911. 173 indexed citations
6.
Tertyshnikova, Svetlana, Ronald J. Knox, Mary Jane Plym, et al.. (2005). BL-1249 [(5,6,7,8-Tetrahydro-naphthalen-1-yl)-[2-(1 H-tetrazol-5-yl)-phenyl]-amine]: A Putative Potassium Channel Opener with Bladder-Relaxant Properties. Journal of Pharmacology and Experimental Therapeutics. 313(1). 250–259. 52 indexed citations
7.
Sivarao, Digavalli V., Piyasena Hewawasam, Mary Jane Plym, et al.. (2005). Effect of 4-(5-Chloro-2-hydroxyphenyl)-3-(2-hydroxyethyl)-6-(trifluoromethyl)-quinolin-2(1 H)-one (BMS-223131), a Novel Opener of Large Conductance Ca2+-Activated K+ (Maxi-K) Channels on Normal and Stress-Aggravated Colonic Motility and Visceral Nociception. Journal of Pharmacology and Experimental Therapeutics. 313(2). 840–847. 11 indexed citations
8.
Myers, Robert A., Mary Jane Plym, Laura J. Signor, & Nicholas J. Lodge. (2004). 1‐(2‐pyrimidinyl)‐piperazine, a buspirone metabolite, modulates bladder function in the anesthetized rat. Neurourology and Urodynamics. 23(7). 709–715. 9 indexed citations
9.
Tenney, Daniel J., Steven M. LeVine, R.E. Rose, et al.. (2004). Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine. Antimicrobial Agents and Chemotherapy. 48(9). 3498–3507. 411 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephanie Fang–Tzu Kuo Breakdown of academic impact, for papers by Lucy Costantino Breakdown of academic impact, for papers by Wiesław Kryczka Breakdown of academic impact, for papers by Emilio Suárez Breakdown of academic impact, for papers by Hye Young Chang Breakdown of academic impact, for papers by Takeaki Satoh Breakdown of academic impact, for papers by Kornelija Suveizdytė Breakdown of academic impact, for papers by Jean‐Baptiste Trabut Breakdown of academic impact, for papers by Herbert L. Lim Breakdown of academic impact, for papers by Chiharu Ohue
Rankless by CCL
2026